Menang O - Search Results

1

Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review.

Menang O, Kuemmerle A, Maigetter K, Burri C. Menang O, et al. BMJ Open. 2023 Sep 14;13(9):e071079. doi: 10.1136/bmjopen-2022-071079. BMJ Open. 2023. PMID: 37709326 Free PMC article. Review.

2

Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.

Jusot V, Chimimba F, Dzabala N, Menang O, Cole J, Gardiner G, Ofori-Anyinam O, Oladehin O, Sambakunsi C, Kawaye M, Stegmann JU, Guerra Mendoza Y. Jusot V, et al. Among authors: menang o. Drug Saf. 2020 Jun;43(6):583-593. doi: 10.1007/s40264-020-00925-4. Drug Saf. 2020. PMID: 32239447 Free PMC article.

3

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa.

Stegmann JU, Jusot V, Menang O, Gardiner G, Vesce S, Volpe S, Ndalama A, Adou F, Ofori-Anyinam O, Oladehin O, Mendoza YG. Stegmann JU, et al. Among authors: menang o. BMC Public Health. 2022 Aug 17;22(1):1568. doi: 10.1186/s12889-022-13867-6. BMC Public Health. 2022. PMID: 35978276 Free PMC article.

4

Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.

Koike ME, Gattás VL, Lucchesi MBB, Moura de Oliveira MM, Vanni T, Thomé BDC, Menang O, Socquet M, Precioso AR. Koike ME, et al. Among authors: menang o. Vaccine. 2019 Dec 10;37(52):7560-7565. doi: 10.1016/j.vaccine.2019.09.082. Epub 2019 Oct 4. Vaccine. 2019. PMID: 31590933

5

Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.

Vanni T, Thomé BDC, Oliveira MMM, Gattás VL, Salomão MDG, Koike ME, Lucchesi MBB, Braga PE, Piorelli RO, Viscondi JYK, Mondini G, da Silva A, Espínola HM, Santos JDP, Dias de Nóvoa Rocha SH, Weckx LY, Menang O, Soquet M, Precioso AR. Vanni T, et al. Among authors: menang o. PLoS One. 2021 Feb 11;16(2):e0246540. doi: 10.1371/journal.pone.0246540. eCollection 2021. PLoS One. 2021. PMID: 33571237 Free PMC article. Clinical Trial.

6

Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan Region.

Mendoza YG, Jusot V, Adou F, Ota M, Elenge DM, Begum T, Mdladla N, Menang O, Yavo JC, Kamagaté M. Mendoza YG, et al. Among authors: menang o. Drug Saf. 2024 Feb;47(2):147-159. doi: 10.1007/s40264-023-01368-3. Epub 2023 Nov 15. Drug Saf. 2024. PMID: 37966696 Free PMC article.

7

Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.

Jusot V, Chimimba F, Dzabala N, Menang O, Cole J, Gardiner G, Ofori-Anyinam O, Oladehin O, Sambakunsi C, Kawaye M, Stegmann JU, Mendoza YG. Jusot V, et al. Among authors: menang o. Drug Saf. 2021 Jun;44(6):723. doi: 10.1007/s40264-021-01064-0. Drug Saf. 2021. PMID: 33788174 Free PMC article. No abstract available.

8

Prevalence of falciparum malaria together with acute diarrhoea in children residing in a malaria endemic zone.

Nkuo-Akenji TK, Menang ON. Nkuo-Akenji TK, et al. Among authors: menang on. Afr J Health Sci. 2005 Jan-Jun;12(1-2):26-30. doi: 10.4314/ajhs.v12i1.30797. Afr J Health Sci. 2005. PMID: 17298136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page